Telmisartan and Uptravi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Telmisartan (telmisartan) and Uptravi (selexipag). Common drug interactions include diarrhoea among females and ascites among males.
The phase IV clinical study analyzes what interactions people have when they take Telmisartan and Uptravi. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
What is Uptravi?
Uptravi has active ingredients of selexipag. eHealthMe is studying from 26,576 Uptravi users. Check the latest studies of Uptravi.
14 people who take Telmisartan and Uptravi together, and have interactions are studied.

What are the common drug interactions of Telmisartan and Uptravi, by gender? *:
female:
- Diarrhoea
- Headache (pain in head)
- Hypotension (abnormally low blood pressure)
- Dyspnoea (difficult or laboured respiration)
- Pneumonia
- Hypoaesthesia (reduced sense of touch or sensation)
- Limb discomfort (discomfort in leg)
- Nausea (feeling of having an urge to vomit)
- Pain in extremity
- Pyrexia (fever)
male:
- Ascites (accumulation of fluid in the abdominal cavity)
- Cardiac failure congestive
- Weight increased
- Colon cancer
- Post procedural haemorrhage (post procedural bleeding)
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Right ventricular failure (right half of the heart fails to work)
- Cardiac failure
- Dyspnoea (difficult or laboured respiration)
- N-terminal prohormone brain natriuretic peptide increased
What are the common drug interactions of Telmisartan and Uptravi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Diarrhoea
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hypotension (abnormally low blood pressure)
- Limb discomfort (discomfort in leg)
- Nausea (feeling of having an urge to vomit)
- Pain in extremity
- Pyrexia (fever)
- Visual acuity reduced (reduced clearness of vision)
- Angioedema (rapid swelling of the dermis)
60+:
- Pneumonia
- Diarrhoea
- Anaemia (lack of blood)
- Cellulitis (infection under the skin)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- General physical health deterioration (weak health status)
- Blood pressure decreased
- Hypotension (abnormally low blood pressure)
- Depressed level of consciousness
- Eating disorder
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 12 people, 85.71%
- Anaemia (lack of blood): 4 people, 28.57%
- Pneumonia: 3 people, 21.43%
- Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 14.29%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
- Cardiac Failure: 2 people, 14.29%
- Constipation: 2 people, 14.29%
- Cough: 2 people, 14.29%
- Diarrhea: 2 people, 14.29%
- Gastritis (inflammation of stomach): 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Telmisartan and Uptravi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Telmisartan (9,163 reports)
- Uptravi (26,576 reports)
Browse all drug interactions of Telmisartan and Uptravi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Uptravi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Uptravi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on telmisartan and selexipag (the active ingredients of Telmisartan and Uptravi, respectively), and Telmisartan and Uptravi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Ivabradine Hydrochloride and Bisoprolol Fumarate - 6 seconds ago
- Could Oxaliplatin cause Dilatation Ventricular? - 13 seconds ago
- Drug interactions of Zolpidem Tartrate and Quinine Sulfate - 22 seconds ago
- Drug interactions of Zofran and Mevacor - 41 seconds ago
- Could Travatan Z cause Weakness? - 41 seconds ago
- Could Amrix cause Dyspnea? - 42 seconds ago
- Could Avandia cause Blockage Of Leg Arteries? - 43 seconds ago
- Could Nitroglycerin cause Protein Urine Present? - 50 seconds ago
- Could Dexamethasone cause Fasciitis? - 52 seconds ago
- Could Cycrin cause Joint Pain? - 52 seconds ago